GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Evolus Inc (FRA:EVL) » Definitions » 5-Year Yield-on-Cost %

Evolus (FRA:EVL) 5-Year Yield-on-Cost % : 0.00 (As of Apr. 13, 2025)


View and export this data going back to 2018. Start your Free Trial

What is Evolus 5-Year Yield-on-Cost %?

Evolus's yield on cost for the quarter that ended in Dec. 2024 was 0.00.


The historical rank and industry rank for Evolus's 5-Year Yield-on-Cost % or its related term are showing as below:



FRA:EVL's 5-Year Yield-on-Cost % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 2.44
* Ranked among companies with meaningful 5-Year Yield-on-Cost % only.

Competitive Comparison of Evolus's 5-Year Yield-on-Cost %

For the Drug Manufacturers - Specialty & Generic subindustry, Evolus's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Evolus's 5-Year Yield-on-Cost % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Evolus's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Evolus's 5-Year Yield-on-Cost % falls into.


;
;

Evolus 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Evolus is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

Evolus  (FRA:EVL) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Evolus 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of Evolus's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


Evolus Business Description

Traded in Other Exchanges
Address
520 Newport Center Drive, Suite 1200, Newport Beach, CA, USA, 92660
Evolus Inc is a performance beauty company with a customer-centric approach to delivering breakthrough products in the self-pay aesthetic market. The company's first commercial product is Jeuveau, a proprietary 900 kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe glabellar lines, also known as frown lines, in adults. Its primary market is the cash-pay aesthetic market, which includes medical products purchased by physicians and other customers that are then sold to consumers or used in procedures for aesthetic indications. It generates product revenue from the sale of Jeuveau in the United States and Europe, and service revenue from distribution partners in Canada.

Evolus Headlines

No Headlines